September 2024 - Page 5 of 13

MondaySep 23, 2024 9:00 am

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Works to Meet Increased Energy Demand in Europe, Türkiye

Europe’s energy landscape has undergone significant changes recently, in part due to the geopolitical tensions between Russia and Ukraine. Türkiye’s energy demand is growing rapidly with an expanding economy and population. Amid this growth, Trillion Energy International has emerged as a significant player in the natural gas sector. The demand for natural gas in Europe and Türkiye is on the rise, driven by a combination of geopolitical, economic and environmental factors. As the world grapples with energy security and sustainability, natural gas has emerged as a crucial component of the energy mix in these regions. The increased demand for natural…

MondaySep 23, 2024 8:30 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Partnership with Staque to Accelerate Commercial Adoption of Quantum in the Middle East

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has announced its partnership with Staque, a leading consulting and development practice with a focus on artificial intelligence (“AI”), blockchain and quantum computing. According to the announcement, the two companies will work to“foster collaboration and usage of quantum computing solutions for optimization and AI applications.” The companies aim to accelerate the commercial adoption of annealing quantum computing across the Middle East. “We believe organizations must embrace today’s advanced technologies such as quantum computing and AI in…

MondaySep 23, 2024 8:30 am

QualityStocksNewsBreaks – AROYA Sponsors, Exhibits at Hall of Flowers Event, Open to the Public for First Time

AROYA, the leading cannabis cultivation platform, is a sponsor of the Hall of Flowers event in California and is exhibiting its state-of-the-art precision irrigation and cultivation technology at the event. The Hall of Flowers Market & Festival is slated for Sept. 21, 2024, in Sonoma, California, and is open to the public for the first time ever. According to the announcement, the company will have special product drops and offer exclusive deals for attendees, who will also be able to participate in demonstrations of the AROYA GO unit and interact with expert AROYA team members at the AROYA exhibit booth.…

FridaySep 20, 2024 3:30 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes and obesity. Recently, the company announced the dosing completion of its human pilot study #2, GLP-1-H24-2, which sought to explore effective oral delivery of GLP-1 drugs. Some evaluated aspects included side effects, blood levels of…

FridaySep 20, 2024 2:30 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Buntanetap

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, secured U.S. patent No. 12,042,482 covering methods for treating traumatic brain injury (“TBI”) and nerve injury with buntanetap, the company’s lead drug candidate. “Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43; by inhibiting their translation, the drug improves synaptic transmission, axonal transport, reduces neuroinflammation, and prevents nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule that inhibits multiple neurotoxic proteins simultaneously, making it a promising solution…

FridaySep 20, 2024 12:45 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product

Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium benzoate. According to the announcement, Bitrex is the most bitter substance in the world, and Nutriband will be using it as an aversive agent in its lead product, AVERSA(TM) Fentanyl, an abuse deterrent fentanyl patch. The company’s abuse-deterrent transdermal technology includes the utilization of a proprietary aversive agent coating that uses taste aversion as a means to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch products. According…

FridaySep 20, 2024 11:40 am

QualityStocksNewsBreaks – Octane Chooses IBN as Official Media Partner for Upcoming Medical Innovation Forum 2024

Octane, an innovative organization building the SoCal of Tomorrow by connecting people, resources and capital to fuel technology growth in Southern California, has chosen IBN (“InvestorBrandNetwork”), a pioneering corporate communications firm and content distributor, as the official media partner for its next month’s Medical Innovation Forum 2024; the two-day event will be held on Oct. 8–9, 2024, in Irvine. California. The theme of this year’s event is “The Seismic Shift in Healthcare: AI & Innovation.” According to the announcement, IBN will heighten recognition and increase awareness of the Octane event among investors, journalists, consumers and the broader public of the Octane event…

FridaySep 20, 2024 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Joins Chicago Quantum Exchange to Help Advance Quantum Science and Commercialization

The partnership is aimed at furthering quantum education and industry adoption efforts D-Wave will engage with the Chicago Quantum Exchange (“CQE”) community on materials science research, quantum education, and the development of practical optimization use cases across multiple sectors D-Wave’s technology, products and training are expected to play a role in the efforts to support and expand quantum commercialization in the Chicago region D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has joined the Chicago Quantum Exchange (“CQE”), a leading quantum research hub connecting academia, industry…

FridaySep 20, 2024 9:45 am

Domestic Violence Victim Data Breach is a Case Example Showing Critical Need for Monitoring Technology of SuperCom Ltd. (NASDAQ: SPCB)

Police in Australia recently reported a data-sharing error that caused domestic violence victims’ addresses to be published to the offenders accused of harassing them The situation demonstrated the vulnerability of the police service’s public safety measures, leading to recommendation that at least one of the victims move to a new residence, and highlighting the critical need for advanced electronic monitoring (“EM”) technology for domestic violence offenders SuperCom Ltd., a secured tracking solutions provider for governments, is focused on ensuring that its superior PureConnect EM platform is available for tracking the movements of offenders under parole and probation supervision, including accused…

FridaySep 20, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations

Lexaria, a global innovator in drug delivery platforms, announced the appointment of Richard Christopher as its new CEO, replacing Chris Bunka who will serve in his new capacity as Executive Strategic Advisor while remaining Chairman of the Board Lexaria also announced entering a Material Transfer Agreement with an undisclosed pharmaceutical industry partner, leading to speculation of which company has taken this formal step to get closer to Lexaria’s technology The company is focusing on this pharmaceutical industry collaboration and on investigations in cardiometabolic and GLP-1 sectors (alternative diabetes and obesity treatments), a huge sector that particularly needs its unmatched technology…

Site Search

Company Search

Month: September 2024